1997
DOI: 10.1016/s0016-5085(97)70110-0
|View full text |Cite
|
Sign up to set email alerts
|

Leiden factor V mutation in four patients with small bowel infarctions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

1999
1999
2010
2010

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(16 citation statements)
references
References 2 publications
0
16
0
Order By: Relevance
“…Factor V Leiden mutation was the only identifiable abnormality in this case. It is recognised as a contributing risk factor in cases of small bowel infarction [7]. Heresbach et al [7] described four such cases, of which two involved arterial thrombosis.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Factor V Leiden mutation was the only identifiable abnormality in this case. It is recognised as a contributing risk factor in cases of small bowel infarction [7]. Heresbach et al [7] described four such cases, of which two involved arterial thrombosis.…”
Section: Discussionmentioning
confidence: 99%
“…It is recognised as a contributing risk factor in cases of small bowel infarction [7]. Heresbach et al [7] described four such cases, of which two involved arterial thrombosis. Factor V Leiden mutation in isolation is not commonly associated with such devastating arterial thrombosis as was seen in this case.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our patient had no acquired risk factors. MVT has also been described in inherited thrombophilias (box 1), including antithrombin deficiency2 and the factor V Leiden mutation 3
Genetic factors predisposing to venous thrombosis

antithrombin deficiency

protein C deficiency

protein S deficiency

factor V Leiden mutation

prothrombin 20210A mutation

The prothrombin gene mutation 20210A is a recently described additional thrombophilic risk factor with an incidence of 2.3% in healthy control subjects and 18% in patients with a personal or family history of DVT 4.
…”
Section: Discussionmentioning
confidence: 99%
“…20 Patients who are heterozygous and homozygous for the FVL mutation have a seven-and 80-fold increased risk of venous thrombosis, respectively, and the strong association of this defect, as well as APC-R, with MVT have been revealed in recent series. 21,22 Splenic vein thrombosis Four (13.8%) patients presented with SVT. One male patient with no other identifiable underlying thrombophilic risk factor had been recently operated on and a malignant suprasellular brain glioma had been removed partially.…”
Section: Mesenteric Vein Thrombosismentioning
confidence: 99%